Graham Capital Management’s BioXcel Therapeutics BTAI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,682	Closed	-$897K	–	1014
2022 Q1	$897K	Buy	2,682 +1,875	+232%	+$627K	0.03%	343
2021 Q4	$262K	Buy	+807	New	+$262K	0.01%	361